Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/8/2018
SIETES contiene 92466 citas

 
 
 1 a 20 de 4521 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita original Cita con resumen
Corvol J-C, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques A-R, Bourdain F, Brandel J-P, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee P-C, Brice A, Vidailhet M, Elbaz A, for the DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 2018;91:e189-201. [Ref.ID 102695]
3.Enlace a cita original Cita con resumen
Vozoris NT, Wang X, Austin PC, O'Donnell DE, Aaron SD, To TM, Gershon AS. Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease . Br J Clin Pharmacol 2018;84:marzo. [Ref.ID 102651]
4.Enlace a cita original Cita con resumen
O'Connell J, Burke E, O'Dwyer C, Donegan C, McCallion P, McCarron M, Henman MC, O'Dwyer M. Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study. Br J Clin Pharmacol 2018;84:marzo. [Ref.ID 102650]
5.Enlace a cita originalTiene citas relacionadas Cita con resumen
Gill SS, Bai AD. Beta testing the potential link between the alpha antagonist tamsulosin and dementia. Pharmacoepidemiol Drug Saf 2018;27:marzo. [Ref.ID 102635]
6.Enlace a cita originalTiene citas relacionadas Cita con resumen
Duan Y, Grady JJ, Albertsen PC, Wu ZH. Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidemiol Drug Saf 2018;27:marzo. [Ref.ID 102634]
7.Enlace a cita original Cita con resumen
Maxwell CJ, Campitelli MA, Hogan DB, Diong C, Austin PC, Amuah JE, Lapane K, Seitz DP, Gill SS, Gruneir A, Wodchis WP, Bronskill SE. Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition. Pharmacoepidemiol Drug Saf 2018;27:marzo. [Ref.ID 102632]
8.Enlace a cita original Cita con resumen
Patel TK, Patel TB. Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis. Eur J Clin Pharmacol 2018;74:junio. [Ref.ID 102626]
9.Enlace a cita original Cita con resumen
Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel Jr EF, Grijalva CG. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med 2018;168:20 de marzo. [Ref.ID 102563]
10.Enlace a cita original Cita con resumen
Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med 2018;378:22 de febrero. [Ref.ID 102557]
11.Enlace a cita original Cita con resumen
Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, Kroenke K, Bair MJ, Noorbaloochi S. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee ostoarthritis pain. The SPACE randomized clinical trial. JAMA 2018;319:6 de marzo. [Ref.ID 102554]
12.Enlace a cita original Cita con resumen
Garattini S, Bertele V. Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicines. Eur J Clin Pharmacol 2018;74:marzo. [Ref.ID 102550]
14. Cita con resumen
González AV, Coulombe J, Ernst P, Suissa S. Long-term use of inhaled corticosteroids in COPD and the risk of fracture. Chest 2018;153:321-8. [Ref.ID 102538]
15. Cita con resumen
Bally M, Beauchamp M-E, Abrahamowicz M, Nadeau L, Brophy JM. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure. Pharmacoepidemiol Drug Saf 2018;27:69-77. [Ref.ID 102531]
16.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dekkers T, Lafeber M, Kramers C. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2018;378:1 de febrero. [Ref.ID 102523]
17.Enlace a cita originalTiene citas relacionadas Cita con resumen
Wang X, Karnieg T. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2018;378:1 de febrero. [Ref.ID 102522]
18.Enlace a cita original Cita con resumen
Montastruc F, Bénard-Laribière A, Noize P, Pambrun E, Diaz-Bazin F, Tournier M, Bégaud B, Pariente A. Antipsychotics use: 2006–2013 trends in prevalence and incidence and characterization of users. Eur J Clin Pharmacol 2018;74:mayo. [Ref.ID 102512]
19. Cita con resumen
Anónimo. Hallucinations and pimavanserin (NUPLAZID), a new kind of drug for psychosis. ISMP Quarter Watch 2018:6. [Ref.ID 102509]
Seleccionar todas
 
 1 a 20 de 4521 siguiente >>